BlackRock Investment Management’s Epizyme, Inc EPZM Stock Holding History

BlackRock Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.85M	Sell	153,062 -432	-0.3%	-$4.51K	﹤0.01%	2268
2016 Q3	$1.51M	Sell	153,494 -382	-0.2%	-$3.49K	﹤0.01%	2396
2016 Q2	$1.58M	Buy	153,876 +12,625	+9%	+$141K	﹤0.01%	2305
2016 Q1	$1.71M	Buy	141,251 +44,855	+47%	+$454K	﹤0.01%	2107
2015 Q4	$1.54M	Buy	96,396 +82	+0.1%	+$1.22K	﹤0.01%	2265
2015 Q3	$1.24M	Sell	96,314 -1,455	-1%	-$29.4K	﹤0.01%	2440
2015 Q2	$2.35M	Buy	97,769 +55,048	+129%	+$1.06M	﹤0.01%	2105
2015 Q1	$802K	Buy	42,721 +7,699	+22%	+$159K	﹤0.01%	2672
2014 Q4	$661K	Sell	35,022 -353	-1%	-$8.25K	﹤0.01%	2832
2014 Q3	$959K	Sell	35,375 -19,851	-36%	-$617K	﹤0.01%	2556
2014 Q2	$1.72M	Buy	55,226 +36,526	+195%	+$860K	﹤0.01%	2201
2014 Q1	$426K	Buy	18,700 +2,283	+14%	+$69.2K	﹤0.01%	3031
2013 Q4	$341K	Sell	16,417 -330	-2%	-$9.57K	﹤0.01%	3121
2013 Q3	$670K	Buy	16,747 +1,669	+11%	+$56.5K	﹤0.01%	2721
2013 Q2	$424K	Buy	+15,078	New	+$387K	﹤0.01%	2943

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Investment Management's EPZM Position: Q4 2016 in Review

BlackRock Investment Management reduced its Epizyme, Inc (EPZM) stake by 0.28% in Q4 2016, selling an estimated $4.51K and leaving 153,062 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

BlackRock Investment Management first reported a position in EPZM in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.35M in Q2 2015. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

BlackRock Investment Management held 153,062 shares of Epizyme, Inc worth $1.85M as of Q4 2016.
BlackRock Investment Management sold 432 Epizyme, Inc shares in Q4 2016, an estimated $4.51K.
Epizyme, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2268 holding.
BlackRock Investment Management first reported a position in Epizyme, Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Epizyme, Inc position peaked at $2.35M in Q2 2015.
94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.